Related Experiment Video
Updated: Jul 4, 2026

An Orthotopic Murine Model of Human Prostate Cancer Metastasis
Published on: September 19, 2013
Androgen regulation of soluble guanylyl cyclasealpha1 mediates prostate cancer cell proliferation
1Department of Biological Sciences, University of Toledo, Toledo, OH 43606, USA.
Abstract:
The growth and progression of prostate cancer are dependent on androgens and androgen receptor (AR), which act by modulating gene expression. Utilizing a gene microarray approach, we have identified the alpha1-subunit gene of soluble guanylyl cyclase (sGC) as a novel androgen-regulated gene. A heterodimeric cytoplasmic protein composed of one alpha and one beta subunit, sGC mediates the widespread cellular effects of nitric oxide (NO). We report here that, in prostate cancer cells, androgens stimulate the expression of sGCalpha1. A cloned human sGCalpha1 promoter is activated by androgen in an AR-dependent manner, suggesting that sGCalpha1 may be a direct AR target gene. Disruption of sGCalpha1 expression severely compromises the growth of both androgen-dependent and androgen-independent AR-positive prostate cancer cells. Overexpression of sGCalpha1 alone is sufficient for stimulating prostate cancer cell proliferation. Interestingly, the major growth effect of sGCalpha1 is independent of NO and cyclic guanosine monophosphate, a major mediator of the sGC enzyme. These data strongly suggest that sGCalpha1 acts in prostate cancer via a novel pathway that does not depend on sGCbeta1. Tissue studies show that sGCalpha1 expression is significantly elevated in advanced prostate cancer. Thus, sGCalpha1 may be an important mediator of the procarcinogenic effects of androgens.
Insights
Androgen receptor (AR) signaling drives prostate cancer growth. We found soluble guanylyl cyclase alpha1 (sGCalpha1) is an AR target gene that promotes cancer cell proliferation via a novel pathway, independent of nitric oxide (NO).
Area of Science:
- Molecular Oncology
- Cell Biology
- Biochemistry
Background:
- Prostate cancer progression relies on androgens and the androgen receptor (AR).
- Soluble guanylyl cyclase (sGC) mediates nitric oxide (NO) effects.
- AR modulates gene expression to control cellular functions.
Purpose of the Study:
- Identify novel androgen-regulated genes in prostate cancer.
- Investigate the role of sGCalpha1 in prostate cancer growth and progression.
- Elucidate the mechanism of sGCalpha1 action in cancer cells.
Main Methods:
- Gene microarray analysis to identify androgen-regulated genes.
- Reporter assays to assess promoter activity and AR-dependency.
- Gene knockdown and overexpression studies in prostate cancer cell lines.
- Analysis of sGCalpha1 expression in human prostate cancer tissues.
Main Results:
- sGCalpha1 identified as a novel androgen-regulated gene.
- Androgens stimulate sGCalpha1 expression in an AR-dependent manner.
- sGCalpha1 is crucial for both androgen-dependent and -independent prostate cancer cell growth.
- sGCalpha1 overexpression enhances prostate cancer cell proliferation.
- sGCalpha1 exerts growth effects independently of the NO-sGC-cGMP pathway.
- Elevated sGCalpha1 expression observed in advanced prostate cancer.
Conclusions:
- sGCalpha1 is a direct AR target gene and promotes prostate cancer growth.
- sGCalpha1 functions through a novel, NO-independent pathway in prostate cancer.
- sGCalpha1 represents a potential therapeutic target for advanced prostate cancer.
Related Concept Videos
GTPases and their Regulation
Large G-proteins, also known...
Mitogens and the Cell Cycle
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Amplifying Signals via Enzymatic Cascade
GPCRs Regulate Adenylyl Cylase Activity
Two...

